Pneumococcal vaccine

In an agreement from 2018, between the State of the Grand Duchy of Luxembourg and the national health insurance fund, it was agreed that the pneumococcal vaccine will not be fully reimbursed to people over 85 years of age. Democratic Party deputy Carole Hartmann asked the Minister for Social Security for the reasons for this age limit.

« Le 1er septembre 2018, une nouvelle convention entre l’État du Grand-Duché de Luxembourg et la Caisse nationale de Santé est entrée en vigueur “portant institution d’un programme de vaccination des personnes âgées de 65 ans et plus, et de certaines personnes à risque contre le pneumocoque”. 

Conformément à ce programme de vaccination, les personnes éligibles ont droit à la prescription et à l’administration du vaccin, à la prise en charge au taux de cent pour cent (100 %) du prix public.

Cependant, il a été convenu que le “droit aux prestations prévues par le programme est garanti jusqu’à l’âge de 85 ans inclus”. En d’autres termes, les personnes âgées de plus de 85 ans n’ont plus droit au remboursement intégral de la vaccination.

À cet égard, j’aimerais poser les questions suivantes à Monsieur le Ministre de la Sécurité sociale :

  • Combien de personnes ont reçu un remboursement au taux de cent pour cent pour la vaccination contre le pneumocoque depuis l’entrée en vigueur de la nouvelle convention ? 
  • Monsieur le Ministre, peut-il fournir des explications concernant la limite d’âge de 85 ans, mentionnée ci-dessus? 
  • Ne s’avère-t-il pas opportun d’étendre le droit à la prise en charge au taux de cent pour cent du prix public, également aux personnes âgées de plus de 85 puisqu’elles sont tout aussi vulnérables que les personnes ciblées ? »


In their response, the ministers state that 12,076 people who bought a pneumococcal vaccine at a pharmacy in Luxembourg in 2020 are between 65 and 85 years old and 1,060 over 85 years old (5.8%).

The Superior Council of Infectious Diseases (CSMI) recommends the vaccination of people aged 65 to 84 inclusive, based on known data on vaccination efficiencies published at the time of the July 2015 recommendation.

The ministers believe however that the CSMI could seize the opportunity to update the recommendations on pneumococcal vaccination for adults.

Would you like this parliamentary question to be translated into English?



More parliamentary questions

Do rapid diagnostic tests help against antibiotic shortages?

France is considering only allowing antibiotics to be prescribed if a rapid diagnostic test is carried out beforehand. This would make it possible to determine with certainty whether the infection is bacterial or viral.
This could on the one hand counteract the lack of antibiotics and on the other hand reduce antibiotic resistance.
DP MPs Gilles Baum and Gusty Graas asked the Minister of Health how many antibiotics have been prescribed in Luxembourg in the last five years and whether doctors should be made more aware of prescribing diagnostic tests.


Is therapeutic housing being commercialised?

Therapeutic housing is currently offered by approved outpatient psychiatric services to people suffering from mental health problems.
Rumours are now circulating that the Ministry of Health is planning to entrust the management of therapeutic housing to a commercial company.
DP MPs Gusty Graas and Gilles Baum asked the Minister for Health whether these rumours were true and, if so, why this course of action was being pursued rather than supporting the existing players in approved outpatient psychiatry.


Is there also abuse of “proton pump inhibitors” in Luxembourg?

According to a recent scientific study, the long-term use of so-called “proton pump inhibitors” (IPP), which are used to treat stomach problems, increases the risk of developing dementia. The DP MP Gusty Graas asked the responsible ministers whether they are aware of this study, what conclusions they draw from it and whether figures on the use of IPPs in Luxembourg are known.